China is going to be way ahead of us in biological treatments because they are willing to actually remove the red tape and in fact encourage scientists to try these sorts of experimental treatments. Meanwhile, we have a dinosaur FDA, a bureaucratic academia second to only Europeans.
The good news is that the rest of the world will benefit from China’s treatment philosophy.
What's the plan in China for when one of these expedited treatments has a terrible side effect?
The FDA's slowness is about maintaining a low level of risk because the reputation cost of a really bad incident is huge.
Well, I'm no ethicist, but I don't think they really care. They'll catalog the results and try again.